Study Finds Ground Zero First Responders Face Heart Risks
More Evidence Surfaced Regarding Health Problems Of Ground Zero First Responders. Evidence continues to mount regarding the health problems faced by Ground Zero first responders. According to a new study from Mount Sinai Medical Center, rescue workers who responded within the first two days of the 9/11 terrorist attacks may be at … [Read more...] about Study Finds Ground Zero First Responders Face Heart Risks
Chantix Recall Urged After Heart Risks
Chantix Recall Urged After A Study Conducted. A Chantix researcher is calling on the U.S. Food & Drug Administration (FDA) to pull the controversial stop-smoking drug from the market after a study he co-authored showed that taking Chantix increased the risk of heart attacks, strokes and other cardiovascular events by as … [Read more...] about Chantix Recall Urged After Heart Risks
Darvon, Darvocet Pulled From Market
Darvon, Darvocet Pulled From Market. The painkillers Darvon and Darvocet (propoxyphene) are being pulled from the market today because of their association with serious or even fatal heart rhythm abnormalities. The US Food & Drug Administration (FDA) is also asking the manufacturers of generic propoxyphene-containing products to … [Read more...] about Darvon, Darvocet Pulled From Market
Findings of Avandia Study Kept Under Wraps
Findings of Avandia Study Kept Under Wraps by Drug Maker. The maker of Avandia had evidence about the drug’s heart risks as early as 1999, but concealed that information from U.S. regulators and the public. According to a new report in The New York Times, SmithKline Beecham, now GlaxoSmithKline, began a study that year to … [Read more...] about Findings of Avandia Study Kept Under Wraps
Senate Avandia Report Flawed
Avandia Potential Heart Risks. GlaxoSmithKline has released a 30-page "white paper", defending itself from charges that it downplayed Avandia's potential heart risks. The white paper followed release of a Senate Finance Committee report that was highly critical of both Glaxo and the U.S. Food & Drug Administration (FDA) … [Read more...] about Senate Avandia Report Flawed
COX-2 Inhibitors Raise Heart Risks
COX-2 Inhibitors More Likely to Raise Heart Risks. A new study that confirms the heart risks associated with a class of drugs called NSAIDs has found that the increased risk correlates to the specific pain-causing molecule they act against. According to the study, NSAIDS that are cox-2 inhibitors are more likely to increase the risks … [Read more...] about COX-2 Inhibitors Raise Heart Risks
Beta Blockers Increase Surgery Risk
Beta Blockers Increase Surgery Risk. A new study on the effects of beta blockers and surgical procedures reveals that patients given a beta blocker—beta blockers are a type of blood pressure drug—to reduce heart risks prior to surgery, were one-third more likely to die within a month and also had double the risk of stroke compared … [Read more...] about Beta Blockers Increase Surgery Risk
Data: Vioxx Heart Risks Began Earlier than Thought
Patients Vioxx Heart Risks. New data obtained by NPR show that patients who took Vioxx even for short periods were at higher risk of heart problems and strokes. An estimated 20 million Americans took the painkiller before Merck & Co. stopped selling it in 2004. In a confidential report to the Food and Drug … [Read more...] about Data: Vioxx Heart Risks Began Earlier than Thought
HMO Bans Bextra Until Safety is Proven
Heart Risks Associated With Bextra. Kaiser Permanente, the nation's largest not-for-profit managed-care provider, has stopped prescribing Bextra until tests show whether the painkiller is safe. The decision came amid "compelling" evidence of heightened heart risks associated with Bextra and a similar drug called Vioxx that … [Read more...] about HMO Bans Bextra Until Safety is Proven
Consumer Advocates Urge Pulling 2 Drugs off Market
Two Drugs Are Being Pulled Off The Market. The Food and Drug Administration should immediately yank Celebrex and Bextra from the market to protect Americans from the drugs' heart risks, according to a petition filed with the agency yesterday by Public Citizen. The petition also requests that the FDA freeze applications for Arcoxia … [Read more...] about Consumer Advocates Urge Pulling 2 Drugs off Market
Study Links Hormone Pills to Heart Risks
Hormone Pills Risk Of Heart Attacks. Women who take hormone replacement pills after menopause nearly double their risk of heart attacks during the first year of treatment, a landmark study concludes. The findings, part of the federally sponsored Women's Health Initiative, also found the popular therapy appears to … [Read more...] about Study Links Hormone Pills to Heart Risks
